We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+13.32%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.72B
AUM Growth
-$123M
Cap. Flow
-$215M
Cap. Flow %
-7.9%
Top 10 Hldgs %
16.65%
Holding
2,200
New
704
Increased
294
Reduced
353
Closed
800

Sector Composition

Rank Sector Weight
1 Financials 15.28%
2 Healthcare 12.35%
3 Industrials 12.24%
4 Technology 10.34%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIR
2051
DELISTED
CIRCOR International, Inc
CIR
-16,479
Closed -$272K
RETA
2052
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-11,374
Closed -$286K
ADER
2053
DELISTED
26 Capital Acquisition Corp
ADER
-43,600
Closed -$430K
RCLFU
2054
DELISTED
Rosecliff Acquisition Corp I Unit
RCLFU
-19,400
Closed -$191K
NSTC.U
2055
DELISTED
Northern Star Investment Corp. III Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTC.U
-16,100
Closed -$158K
QUOT
2056
DELISTED
Quotient Technology Inc
QUOT
-33,168
Closed -$77K
HARP
2057
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-7,005
Closed -$68K
NEX
2058
DELISTED
NexTier Oilfield Solutions Inc.
NEX
-212,311
Closed -$1.57M
PNACW
2059
DELISTED
Prime Number Acquisition I Corp. Warrant
PNACW
-18,000
Closed -$1K
IDEX
2060
DELISTED
Ideanomics, Inc. Common Stock
IDEX
-15,870
Closed -$546K
ARNC
2061
DELISTED
Arconic Corporation
ARNC
-48,391
Closed -$825K
HMACU
2062
DELISTED
Hainan Manaslu Acquisition Corp. Unit
HMACU
-15,000
Closed -$151K
GENQU
2063
DELISTED
Genesis Unicorn Capital Corp. Unit
GENQU
-13,942
Closed -$140K
CPUH
2064
DELISTED
Compute Health Acquisition Corp.
CPUH
-26,200
Closed -$259K
QFTA.U
2065
DELISTED
Quantum FinTech Acquisition Corporation Units, each consisting of one share of Common Stock and one Warrant
QFTA.U
-25,300
Closed -$249K
NMTR
2066
DELISTED
9 Meters Biopharma
NMTR
-45,573
Closed -$196K
PMGMU
2067
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
-24,400
Closed -$240K
SDACU
2068
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
-13,800
Closed -$136K
LSI
2069
DELISTED
Life Storage, Inc.
LSI
-27,184
Closed -$3.01M
FACT.U
2070
DELISTED
Freedom Acquisition I Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
FACT.U
-10,800
Closed -$107K
AZRE
2071
DELISTED
Azure Power Global Limited
AZRE
-49,217
Closed -$273K
ISEE
2072
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-38,006
Closed -$682K
EVLO
2073
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-1,371
Closed -$57K
INDT
2074
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
-7,547
Closed -$395K
STCN
2075
DELISTED
Steel Connect, Inc. Common Stock
STCN
-10,647
Closed -$136K

Similar funds

Ergoteles's Q4 2022 Portfolio in Review

As of Q4 2022, Ergoteles held 2,200 positions worth $2.72B, down 4.3% from $2.85B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ergoteles withdrew a net $215M in Q4 2022, closing 800 positions and reducing 353 holdings. Its most notable exit was Citrix Systems Inc, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ergoteles opened a new position in McKesson worth $43.9M.

  • Ergoteles's largest Q4 2022 buy was McKesson: 117,079 shares worth $43.9M.
  • Ergoteles added most to iShares Biotechnology ETF in Q4 2022, an estimated $85.8M increase.
  • Ergoteles's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $41.8M.
  • Ergoteles fully exited Citrix Systems Inc in Q4 2022, selling an estimated $149M.
  • Ergoteles's ten largest holdings make up 17% of its $2.72B portfolio in Q4 2022.
  • Ergoteles opened 704 new positions and closed 800 in Q4 2022.
  • Ergoteles's portfolio value fell 4.3% quarter-over-quarter to $2.72B.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.